Toronto, Ontario – TheNewswire - (September 19, 2024) - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT; OTC:VPTDF) is pleased to announce the successful completion of its annual audit under the Medical Device Single Audit Program (MDSAP), ISO 13485 Quality Management System, and EU Medical Device Regulation (MDR) requirements by Notified Body. The audit resulted in zero major nonconformities and confirmed Ventripoint Diagnostics Ltd.’s continued compliance with global quality and ...